| Intrinsic Valuation of: ABNB | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 4 | Market Cap | $79B | |||||
| 2021 | - | - (-) | P/E Ratio | 33 | Total Asset | $22B | |||||
| 2022 | $3B | - (-) | Net Income | $3B | Total Debt | $0 | |||||
| 2023 | $4B | 13.2% (-4.1%) | EBITDA | $3B | Total Liab | $14B | |||||
| 2024 | $5B | 16.3% (3.9%) | Opr Margin | 20.78 | Debt/Equity | - | |||||
| 2025 | $5B | 2.8% (-6.7%) | PreTax Margin | 20.78 | BV/Share | 18 | |||||
| 5Y Average FCF | $4B | 12.4% (-2.3%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 10.12% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (12.4%) | ||||||||||
| 2026 | $5B | MBG Intrinsic Value | $36 | ||||||||
| 2027 | $6B | ||||||||||
| 2028 | $6B | ||||||||||
| 2029 | $6B | ||||||||||
| 2030 | $7B | ||||||||||
| 2031 | $7B | ||||||||||
| Terminal Value | $92B | Net Worth/Share | $20 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $78B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $7B | $202 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $0 | WACC | 8.1% | 240 | 253 | 269 | 289 | 312 | |||
| Equity Value | $84B | 9.1% | 210 | 219 | 230 | 244 | 259 | ||||
| Shares Outstanding | 417,930,233 | 10.1% | 186 | 194 | 202 | 211 | 222 | ||||
| 11.1% | 168 | 174 | 180 | 187 | 195 | ||||||
| DCF Intrinsic Value | $202 | 12.1% | 153 | 158 | 162 | 168 | 174 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||